Caricamento...
Treatment of relapsed and refractory Hodgkin Lymphoma
Despite the high first line cure rates in patients with Hodgkin Lymphoma (HL) still 10–20% of patients suffer from relapsed or refractory disease. High dose chemotherapy (HDCT) followed by autologous stem cell transplant (ASCT) is standard of care for suitable patients with relapsed or refractory HL...
Salvato in:
| Pubblicato in: | Semin Hematol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5637390/ https://ncbi.nlm.nih.gov/pubmed/27496309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2016.05.010 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|